Skip to main content

Table 2 Genetic surveillance assays were performed based on tissue sample

From: Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype–phenotype correlation and gene therapy perspective

Gene

Mutation

type

Nucleotide change

Amino acid

change

Amino acid

change

Rate(%)

Chr

Exon

Initial position

Terminal

position

Transcript number

COL4A6

Missense

c.128C > T

p.Pro43Leu

p.P43L

10.5

X

3|45

107,553,994

107,553,994

NM_033641.2

HMGCL

Missense

c.647A > G

p.Asp216Gly

p.D216G

29.6

1

7|9

24,134,728

24,134,728

NM_000191.2

KIFC1

Missense

c.935G > A

p.Arg312His

p.R312H

24.6

6

7|11

33,372,807

33,372,807

NM_002263.3

KPNA7

Missense

c.659C > T

p.Thr220Met

p.T220M

5.2

7

6|10

98,786,164

98,786,164

NM_001145715.2

KSR2

Missense

c.2720G > A

p.Arg907His

p.R907H

8.6

12

19|20

117,907,506

117,907,506

NM_173598.4

MSX2

Missense

c.387G > T

p.Met129Ile

p.M129I

9.9

5

2|2

174,156,169

174,156,169

NM_002449.4

PARP4

Missense

c.3509C > T

p.Thr1170Ile

p.T1170I

10.4

13

29|34

25,016,762

25,016,762

NM_006437.3

RER1

Missense

c.209C > T

p.Ala70Val

p.A70V

5.0

1

4|7

2,330,876

2,330,876

NM_007033.4

SCN10A

Missense

c.5454G > C

p.Leu1818Phe

p.L1818F

6.8

3

27|27

38,739,257

38,739,257

NM_006514.3

VHL

Missense

c.500G > A

p.Arg167Gln

p.R167Q

48.0

3

3|3

10,191,507

10,191,507

NM_000551.3

  1. Gene mutation and tumor mutation burden analysis indicated somatic pathogenic mutation of VHL gene (c.500G > A, p.Arg167Gln). Tumor mutation burden was 0.18/Mb. There is no other mutations in the VHL gene except p.Arg167Gln in the case. The other major gene mutations included COL4A6 (c.128C > T, p.Pro43Leu), HMGCL (c.647A > G, p.Asp216Gly), KIFC1 (c.935G > A, p.Arg312His), KPNA7(c.659C > T, p.Thr220Met), KSR2(c.2720G > A, p.Arg907His), MSX2(c.387G > T, p.Met129Ile), PARP4(c.3509C > T, p.Thr1170Ile), RER1(c.209C > T, p.Ala70Val), SCN10A(c.5454G > C, p.Leu1818Phe)